European Healthtech startup funding raised during Q4 2018.
In Q4 2018, 166 European Healthtech companies raised a combined €2.1B across 170 funding rounds, up 130.0% versus Q4 2017. France led by capital raised, and Balderton Capital was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Other | Nov 2018 | €178M |
| Acticor biotech | Series B | Nov 2018 | €153M |
| Doctolib | Series D+ | Dec 2018 | €150M |
| Sophia Genetics | Series D+ |
8 exits · €139M disclosed.
| Nutrino | Acquisition | Dec 2018 | €91M |
| Sequana Medical | IPO | Dec 2018 | €28M |
| Bokadirekt | Acquisition | Dec 2018 | €21M |
| Dec 2018 |
| €67M |
| Inivata | Series B | Dec 2018 | €46M |
| DentalMonitoring | Other | Dec 2018 | €45M |
| Vivet Therapeutics | Other | Dec 2018 | €45M |
| Syqe Medical | Other | Dec 2018 | €44M |
| Alvotech | Other | Dec 2018 | €44M |
| Snipr Biome | Series A | Dec 2018 | €44M |
| Inflazome | Series B | Nov 2018 | €40M |
| Atai Life Sciences | Series B | Dec 2018 | €38M |
| Camel-IDS | Series A | Nov 2018 | €37M |
| EarlySense | Series D+ | Dec 2018 | €34M |
| HighLife | Series B | Dec 2018 | €32M |
